Lantern Pharma rises 9% on team up with National Cancer Institute for drug candidates Seeking Alpha Jan 12 Written by Health Wildcatters Health Wildcatters Previous Previous Winston-Salem ecosystem builder Agile City awards a total of $450,000 to nine startups Next Next Lantern Pharma Expands Precision Oncology Collaboration with the National Cancer Institute - Accelerating Path to First in Human Clinical Trials for Drug Candidates LP-184 & LP-284
Lantern Pharma rises 9% on team up with National Cancer Institute for drug candidates Seeking Alpha Jan 12 Written by Health Wildcatters Health Wildcatters
